8.49

2.17% 0.18

After Hours: 8.50 0.010 +0.12%

Achieve Life Sciences Inc (ACHV)

Overview News Price History Option Chain Financials Why ACHV Down? Discussions Forecast Stock Split

Achieve Life Sciences Inc stock is traded at $8.49, with a volume of 872.76K. It is up +2.17% in the last 24 hours and up +31.22% over the past month. Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Previous Close:

$8.31

Open:

$8.2

24h Volume:

872.76K

Relative Volume:

0.49

Market Cap:

$873.64M

Revenue:

Net Income/Loss:

$-51.99M

P/E Ratio:

-7.6109

EPS:

-1.1155

Net Cash Flow:

$-45.31M

1W Performance:

+4.81%

1M Performance:

+31.22%

6M Performance:

+85.37%

1Y Performance:

+204.30%

1-Day Range:

$8.10

$8.56

1-Week Range:

$7.82

$8.64

52-Week Range:

$2.62

$8.64

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Name

Achieve Life Sciences Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

425-686-1500

Address

22722 29TH DR. SE, SEATTLE, BC

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

ACHV's Discussions on Twitter

Compare ACHV vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACHV Achieve Life Sciences Inc	8.49	825.28M	0	-51.99M	-45.31M	-1.1155
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-21-26	Initiated	Canaccord Genuity	Buy
Nov-25-25	Initiated	Citizens JMP	Mkt Outperform
Aug-21-25	Initiated	H.C. Wainwright	Buy
Nov-14-24	Initiated	Rodman & Renshaw	Buy
Sep-27-24	Initiated	Raymond James	Strong Buy
May-10-23	Reiterated	Maxim Group	Buy
Jun-23-21	Initiated	Oppenheimer	Outperform

View All

Achieve Life Sciences Inc Stock (ACHV) Latest News

Sep 07, 2026

Frazier Life Sciences Management L.P. Buys New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat

Sep 07, 2026

Sep 05, 2026

Achieve Life Sciences Stock Price Forecast. Should You Buy ACHV? - StockInvest.us

Sep 05, 2026

Sep 03, 2026

Achieve Life Sciences Grants Equity Awards to 7 New Employees Under 2024 Inducement Plan - Quiver Quantitative

Sep 03, 2026

Seven new employees receive stock awards from Achieve Life Sciences - Stock Titan

Sep 03, 2026

Achieve Life Sciences (NASDAQ:ACHV) Sets New 1-Year HighHere's What Happened - MarketBeat

Sep 03, 2026

Sep 02, 2026

BlackRock Inc. Invests $34.43 Million in Achieve Life Sciences, Inc. $ACHV - MarketBeat

Sep 02, 2026

Sep 01, 2026

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Up 5.2%Time to Buy? - MarketBeat

Sep 01, 2026

Alyeska Investment Group L.P. Acquires Shares of 1,925,722 Achieve Life Sciences, Inc. $ACHV - MarketBeat

Sep 01, 2026

Aug 30, 2026

Jupiter Topco LLC Acquires Shares of 2,751,032 Achieve Life Sciences, Inc. $ACHV - MarketBeat

Aug 30, 2026

Aug 28, 2026

Spruce Street Capital LP Purchases Shares of 736,637 Achieve Life Sciences, Inc. $ACHV - MarketBeat

Aug 28, 2026

Aug 27, 2026